Company profile: Spider stories.
SpiderBiotech is a biotech company that has carried out extensive research and development on peptide-based anti-infectives, with five people involved in R&D activities and a strong network of industrial and academic partners experienced in the field of anti-infectives. SpiderBiotech has also created a proprietary library of bioactive peptides and lipopeptides (both linear and dendrimeric) active against bacterial and viral infections. At the moment they have two ongoing projects: the most advanced is focused on the development of a panel of peptide based antibiotics. The second project is related to novel antiviral drugs to treat acyclovir resistant Herpes virus infections.
Giuliani
Andrea
A
SpiderBiotech S.r.l., via Ribes 5-10010 Colleretto Giacosa (TO), c/o Bioindustry Park Canavese, Italy. info@spiderbiotech.com
D000890:Anti-Infective Agents / Q000494:pharmacology; D000998:Antiviral Agents / Q000494:pharmacology; D001709:Biotechnology; D012109:Research Support as Topic
D000890:Anti-Infective Agents; D000998:Antiviral Agents